Abstract
Introduction
Obesity is a major determinant of mortality of all causes including cardiovascular disease in industrial countries [1] . Adipocytes in expanded fat are active secretory cells capable of releasing lipid mediators and a variety of cytokines, the so-called adipokines [2] . Many studies in human beings and in various animal models have shown that obesity is strongly related to the development of atherosclerosis [3, 4] . Adipose tissue has a prominent role in the development of a low-grade systemic inflammatory state that contributes to obesity-associated vascular dysfunction and cardiovascular risk [5] . The local secretion of adipokines by perivascular fat may provide a new direct link between obesity and vascular complications [6] [7, 8] . Adiponectin (AN) is an anti-atherogenic adipokine and hypoadiponectinemia is not only associated with obesity but also with cardiovascular disease and diabetes [9] . VEGF (Fig. 1E) . 
. However, the mechanism how perivascular fat increases the risk of metabolic and cardiovascular disease is not yet fully elucidated. Endothelial cells and smooth muscle cells (SMC) represent the major cell types of the artery wall preserving vessel wall homeostasis. The migration of vascular smooth muscle cells (VSMC) from the media to intima and their concomitant proliferation occurring in the synthetic state are critical causes of arterial wall thickening. Adipokines such as leptin and resistin have been shown to affect the vasculature by influencing the proliferation and function of SMC

Materials and methods
Materials
Measurement of nitric oxide production in hVSMC
Results
CM generated in the presence of AN reduces proliferation of hVSMC
We could show that the treatment with CM led to a robust induction of proliferation (Fig. 1A, B) and migration (Fig. 1D, E [13] (Fig. 2) . The proliferative effect of CMAN was substantially reduced as compared to CM, whereas AN alone had no effect on hVSMC proliferation (Fig. 2A) . AN added freshly to CM (CM ϩ AN) just before incubating with hVSMC had no effect on the CMinduced proliferation. These findings are in agreement with our view of an autocrine function of AN [13] (Fig. 3C) . Although CM and OA alone had no effect on the expression of VCAM-1, the combination of both showed a nearly 2-fold increase in the expression of VCAM-1 compared to control (Fig. 3D ). (Fig. 4C) . (Fig. 5A, B) . Compound I229 is a benzimidazole derivative, which showed an IC50 value of 1.9 nM against the IKK complex [17] .
CM and
We did not observe enhanced phosphorylation of ERK after treatment with the combination of CM and OA (data not shown).
mTOR and IKK inhibition abolish CM-, OAand CMOA-induced proliferation of hVSMC
Inhibition of both mTOR by rapamycin and IKK by compound I229 totally abrogated CM-and OA-induced proliferation of hVSMC. Both inhibitors also abolished the synergistic effect of CM and OA and restored the basal proliferation level
CM and OA induce iNOS expression, VEGF release and nitric oxide production in hVSMC
We determined iNOS expression in hVSMC after incubation with CM, OA and CMOA for 24 hrs (Fig. 6A ). CM and OA treatment had
Fig. 2 Analysis of CM generated in the absence or presence of AN. CM were generated for 48 hrs with or without 10 nM full length AN (CMAN). Further, AN was added to CM just before the incubation with hVSMC (CM ϩ AN). (A) Effect of AN, CMAN and CM ϩ AN on BrdU incorporation into DNA in hVSMC. Data are expressed relative to the basal control value, which was set as 100%. (B) Analysis of ICAM-1 expression after 24 hrs incubation with CMAN. Total cell lysates were resolved by SDS-PAGE and immunoblotted with a specific ICAM-1 antibody. Data are means Ϯ S.E.M. of three independent experiments and three different adipocyte donors. *P Ͻ 0.05 compared to control. no significant effect on iNOS expression. However, the combination of both induced a 2.3-fold increase of iNOS expression in SMC. It is well established that an increased iNOS expression leads to an enhanced VEGF production in different cell types [18-20]. CM alone contains 122 Ϯ 6 pg/ml VEGF (n ϭ 16). Both CM and OA increased VEGF concentration in SMC medium 2.1-and 2.3-fold, respectively, taking into account the endogenous VEGF content of CM (Fig. 6B). In addition, CMOA increased VEGF concentration in a synergistic manner (5.5-fold). Concomitantly, a significant increase in nitric oxide production by 1.5-fold was observed in hVSMC after incubation with the combination CMOA (Fig. 6C). VEGF treatment showed a significant effect (2.5-fold) on proliferation and the combination of VEGF and OA markedly enhanced the proliferation in an additive way (5-fold) (Fig. 6D). Inhibition of NOS by L-nitro-l-arginine methyl ester (NAME) had no effect on the proliferation induced by CM and OA alone, yet it completely abolished the synergistic effect of the two stimuli.
Notably, an additive proliferative effect of CM and OA was still observed (Fig. 6E) .
Comparison of proliferative capacity between CM from subcutaneous and perivascular adipose tissue
In order to validate our findings obtained with subcutaneous fat, we also assessed the proliferative activity of epicardial fat, which is a perivascular fat depot. CM of both paired subcutaneous and perivascular fat depots were generated from adipose tissue explants from the same patient. Figure 7 shows, that both subcutaneous and epicardial CM induced a significant 1.6-fold proliferation of hVSMC. These results suggest that secreted factors responsible for the induced proliferation are fat depot independent. data demonstrating that AN is able to suppress the expression of adhesion molecules in endothelial cells [27] . [13] , we presumed that the AN content in CM might be responsible for the differences in the proliferative potency of CM. Arita and colleagues showed that AN inhibits growth factorinduced proliferation and migration of human aortic SMC by binding these growth factors [10] . Here [28] , migration [29] and plays a central role in obesity and fatty acid-induced atherosclerosis [30] . In the current study we could reproduce these effects of OA in hVSMC whereas PA had no effect. This difference between PA and OA are not apoptosis related as both fatty acids do not induce apoptosis at the concentrations used [31] . However, different effects on VSMC proliferation and migration could be explained by differential activation of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1␣ expression by OA and PA [32, 33] . Zhang [34] . Proliferation of hVSMC is also regulated by nuclear transcription factors including NF-B. In SMC cultures, NF-B is activated by growth stimulants and cytokines [40] [41] [42] 
Fig. 3 Effect of OA and PA (100 mol/l) on hVSMC proliferation (A), migration (B) and the expression of adhesion molecules ICAM-1 (C) and VCAM-1 (D). (A) For
CM of human adipocytes contains various growth-promoting and migrative factors such as VEGF, fibroblast growth factor, insulin-like growth factor, plasminogen-derived growth factor (PDGF) and angiotensin II. In our study, the majority of CM induced a 3-4-fold proliferation of hVSMC whereas just a few CM lacked this effect. Measuring AN in all used CM, we could demonstrate that a low AN content is associated with high proliferative action of CM. As earlier work demonstrates that AN exerts an autocrine action on adipocytes decreasing the release of various adipokines
